NCT00812344View on ClinicalTrials.gov

Effect of Ketoconazole on Biliary Excretion of AZD0837

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Healthy
Interventions
DRUG

AZD0837

Oral solution, dosing through the Loc-I-Gut catheter, single dose

DRUG

Ketoconazole

tablets, orally, once daily for 3 days

DRUG

ketoconazole

dissolved tablets, dosing through the Loc-I-Gut catheter, single dose

Trial Locations (1)

Unknown

Research Site, Uppsala

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY